<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0795">
 <label>158</label>
 <element-citation publication-type="journal" id="ref0790">
  <person-group person-group-type="author">
   <name>
    <surname>Migone</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Bolmer</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zhong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Corey</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vasconcelos</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Buccellato</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax</article-title>
  <source>Antimicrob Agents Chemother</source>
  <volume>59</volume>
  <issue>2</issue>
  <year>2015</year>
  <fpage>1145</fpage>
  <lpage>1151</lpage>
  <pub-id pub-id-type="pmid">25487792</pub-id>
 </element-citation>
</ref>
